🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

8 results for “Dapagliflozin” Clear

  1. dapagliflozin

    FORXIGA AstraZeneca

    ORAL approved

    A10BK01

  2. dapagliflozin + metformin

    XIGDUO XR 5/1000 AstraZeneca

  3. dapagliflozin + sitagliptin

    SIDAPVIA 10/100 AstraZeneca

  4. dapagliflozin propylene glycolate hydrate

    FORXIGA INITIAL APPROVAL

  5. dapagliflozin || metformin

    DAPAGLIFLOZIN AND METFORMIN

    approved

  6. dapagliflozin, metformin hydrochloride

    DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

    approved

  7. dapagliflozin, saxagliptin monohydrate

    DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE

    ORAL approved

  8. saxagliptin + dapagliflozin

    QTERN 5/10 AstraZeneca

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources